Javascript must be enabled to continue!
Natural history of primary biliary cirrhosis
View through CrossRef
The natural history of primary biliary cirrhosis (PBC) has improved significantly over the last two decades. Most patients are diagnosed with asymptomatic PBC (a‐PBC). The prognosis of a‐PBC is usually better than that of symptomatic PBC (s‐PBC). Among a‐PBC patients, some remain asymptomatic, whereas others progress to s‐PBC. The prognosis of s‐PBC is still poor and the main cause of death in PBC is liver failure. Other complications, such as esophageal varices and hepatocellular carcinoma, also affect the prognosis of PBC patients. Ursodeoxycholic acid treatment improves the prognosis of PBC patients in the early stage. There seems to be several types of PBC progression.
Title: Natural history of primary biliary cirrhosis
Description:
The natural history of primary biliary cirrhosis (PBC) has improved significantly over the last two decades.
Most patients are diagnosed with asymptomatic PBC (a‐PBC).
The prognosis of a‐PBC is usually better than that of symptomatic PBC (s‐PBC).
Among a‐PBC patients, some remain asymptomatic, whereas others progress to s‐PBC.
The prognosis of s‐PBC is still poor and the main cause of death in PBC is liver failure.
Other complications, such as esophageal varices and hepatocellular carcinoma, also affect the prognosis of PBC patients.
Ursodeoxycholic acid treatment improves the prognosis of PBC patients in the early stage.
There seems to be several types of PBC progression.
Related Results
Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis
Distribution of pyruvate dehydrogenase dihydrolipoamide acetyltransferase (PDC-E2) and another mitochondrial marker in salivary gland and biliary epithelium from patients with primary biliary cirrhosis
Previous studies in which quantitative immunofluorescence was used have shown that certain biliary epithelial cells in liver with primary biliary cirrhosis show increased levels of...
109. Clinical Characteristics and Outcomes of Staphylococcus aureus Bacteremia From a Biliary Source
109. Clinical Characteristics and Outcomes of Staphylococcus aureus Bacteremia From a Biliary Source
Abstract
Background
Staphylococcus aureus can cause various types of infection, but involvement of biliary tract is rare. There ...
Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study
Adverse Events After Carbon-Ion Radiotherapy (CIRT) for Hepatocellular Carcinoma and Risk Factors for Biliary Stricture After CIRT: A Retrospective Study
Background/Objectives: This study investigated the timing of adverse events (AEs) after carbon-ion radiotherapy (CIRT) for hepatocellular carcinoma (HCC) and identified the risk fa...
Echocardiographic features, mortality, and adrenal function in patients with cirrhosis and septic shock
Echocardiographic features, mortality, and adrenal function in patients with cirrhosis and septic shock
Objectives: Cirrhosis of the liver is associated with an increased susceptibility to bacterial infections capable of causing septic shock and with a basal hyperdynamic circulatory...
Endoscopic Management for Difficult Biliary Cases in the era of Laparoscopic Surgery
Endoscopic Management for Difficult Biliary Cases in the era of Laparoscopic Surgery
Abstract
Background: Biliary disorders are still the most challenging cases in the field of gastroenterology, as comprehensive clinical evaluation and treatment considerati...
Stage Diagnosis of Hepatitis B Cirrhosis Based on Noninvasive Eye Examination
Stage Diagnosis of Hepatitis B Cirrhosis Based on Noninvasive Eye Examination
Background: The liver is an important organ of the human body and has the greatest ability to eliminate harmful toxins. Objectives: Hepatitis B cirrhosis is a progressive and life-...
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection
The prevalence of cirrhosis and hepatocellular carcinoma in patients with human immunodeficiency virus infection
Abstract
Cirrhosis is a leading cause of death among patients infected with human immunodeficiency virus (HIV). We sought to determine risk factors for and time trends ...
Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension
Proton pump inhibitor treatment aggravates bacterial translocation in patients with advanced cirrhosis and portal hypertension
ABSTRACT
Recent studies have linked proton pump inhibitor (PPI) treatment to increased complications of cirrhosis, such as bacterial infections and hepatic e...

